Search results
Results From The WOW.Com Content Network
The Federal Trade Commission had its first win earlier this week in its crusade to block drug company deals: Sanofi on Monday ended its up-to-$735 million licensing deal with Maze Therapeutics.
AstraZeneca claimed the deal undervalued the company. [15] 4 2014 Pfizer: Astra Zeneca: 99 127 AstraZeneca claimed the deal undervalued the company. [16] 5 1999 Pfizer: Warner–Lambert: 82.4 151 Pfizer made a hostile bid, just after the announcement of a $72 billion deal with Wyeth, the eventual purchase price would be in excess of $90 billion ...
The abbreviation is not always a short form of the word used in the clue. For example: "Knight" for N (the symbol used in chess notation) Taking this one stage further, the clue word can hint at the word or words to be abbreviated rather than giving the word itself. For example: "About" for C or CA (for "circa"), or RE.
The Liusons, a traditional Chinese family has been involved in the pharmaceutical industry since 1959 through Pacific Pharma, an importer and wholesaler of drugs. [3] In 1983, Pacific Pharma shifted to investing on generic drugs. [3] The company initially largely sold generic drugs wholesale to government hospitals. [4]
An American-style 15×15 crossword grid layout. A crossword (or crossword puzzle) is a word game consisting of a grid of black and white squares, into which solvers enter words or phrases ("entries") crossing each other horizontally ("across") and vertically ("down") according to a set of clues. Each white square is typically filled with one ...
Big Pharma may refer to: Big Pharma conspiracy theories; Pharmaceutical industry; Pharmaceutical lobby; Pharmaceutical Research and Manufacturers of America (PhRMA ...
Apart from the aforementioned milestone and royalty payment, Hong Kong-based CSPC will also get an upfront payment of $100 million as part of the deal. CSPC will develop an early-stage, novel ...
NEW YORK (Reuters) -U.S. Senator Elizabeth Warren has asked antitrust regulators to scrutinize a $16.5 billion deal in which Novo Nordisk's controlling shareholder would acquire contract drug ...